|MPN Roundtable Year in Review: The Impact of New Data in Myelofibrosis on the Evolving Treatment Landscape|
CME, CPE, CNE
Prithviraj Bose, MD; Ruben Mesa, MD, FACP
|Release Date: February 05, 2020|
Expiration Date: February 05, 2021
The community multidisciplinary healthcare provider seeking to improve competence and confidence in the utilization of approved JAK inhibitor therapy and increase their knowledge of emerging treatment options will benefit from this expert review of key data in myelofibrosis from 2019 by Drs. Bose and Mesa. Participants will also be enlightened by how this data can impact their current practice and gain confidence in their ability to communicate with patients to ensure they make informed treatment decisions.
This activity was previously presented as a webinar with live Q&A in January of 2020. Please note: If you participated in the live webinar, you are ineligible to receive an additional 1.0 contact hour of credit and may not re-submit for credit previously awarded.Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.
|Begin, Earn CreditView Only, No Credit|